Login | Register

Alzheimer’s Treatment Halts Symptoms For 3 Years

A group of Alzheimer's patients treated for 3 years with an immunotherapy drug showed no symptom decline over the treatment period. The patients were taking part in a small placebo-controlled phase 2 trial testing Baxter's intravenous immunoglobulin (IVIG) as an immunotherapy for Alzheimer's...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *